Институт Экспериментальной Патологии, Онкологии И Радиобиологии Им. Р.Е. Кавецкого Нан Украины
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институт Экспериментальной Патологии, Онкологии И Радиобиологии Им. Р.Е. Кавецкого Нан УкраиныfiledCriticalИнститут Экспериментальной Патологии, Онкологии И Радиобиологии Им. Р.Е. Кавецкого Нан Украины
Priority to UAU201304135UpriorityCriticalpatent/UA84044U/en
Publication of UA84044UpublicationCriticalpatent/UA84044U/en
Measuring Or Testing Involving Enzymes Or Micro-Organisms
(AREA)
Abstract
A method for predicting sensitivity to neoadjuvant therapy in patients with breast cancer with verified diagnosis consists in that prior to the first course of neoadjuvant chemotherapy in patients with breast cancer the level of serum ferritin is determined and ferritin values from 10 to 200 ng/ml predict sensitivity of tumors to neoadjuvant chemotherapy, and for values of ferritin levels 200 ng/ml - resistance to neoadjuvant chemotherapy.
UAU201304135U2013-04-022013-04-02Method for prediction of sensitivity to neoadjuvant therapy in breast cancer patients
UA84044U
(en)
Assays, methods and kits for analyzing sensitivity and resistance to anti-cancer drugs, predicting a cancer patient's prognosis, and personalized treatment strategies